Combined 5-fluorouracil, low-molecular-weight heparin, and silicone oil in the management of complicated retinal detachment with proliferative vitreoretinopathy grade C

Ophthalmic Surg Lasers Imaging. 2007 Jul-Aug;38(4):276-82. doi: 10.3928/15428877-20070701-02.

Abstract

Background and objective: To determine whether combined 5-fluorouracil (5-FU) and low-molecular-weight heparin (LMWH) could improve the outcome of vitreoretinal surgery with silicone oil for the management of complicated retinal detachment with proliferative vitreoretinopathy (PVR) grade C.

Patients and methods: In an interventional, controlled, nonrandomized clinical trial, 33 eyes with complicated retinal detachment and PVR underwent vitrectomy with silicone oil and perioperative infusion of 5-FU and LMWH (study group) and 31 eyes underwent vitrectomy with silicone oil without adjunctive medication (control group).

Results: In the study group, 24 eyes (72.7%) had the retina attached and 9 had a retinal redetachment (27.3%) at 6 months. In the control group, 25 eyes (80.6%) had the retina attached and 6 eyes (19.4%) had a retinal redetachment at 6 months (chi-square: 0.53, P > .05). One-year postoperative data were available for 17 eyes in the study group and 19 eyes in the control group. Four eyes in each group (23.5% and 21%, respectively) developed retinal redetachment (chi-square: 0.03, P > .05).

Conclusions: Combined 5-FU and LMWH does not seem to improve the outcome of vitreoretinal surgery with silicone oil for the management of complicated retinal detachment with PVR grade C.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antimetabolites / administration & dosage
  • Antimetabolites / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Fluorouracil / administration & dosage
  • Fluorouracil / therapeutic use*
  • Heparin, Low-Molecular-Weight / administration & dosage
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Recurrence
  • Retinal Detachment / complications
  • Retinal Detachment / surgery*
  • Silicone Oils / administration & dosage*
  • Treatment Outcome
  • Visual Acuity
  • Vitrectomy / methods*
  • Vitreoretinopathy, Proliferative / drug therapy*
  • Vitreoretinopathy, Proliferative / etiology

Substances

  • Antimetabolites
  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Silicone Oils
  • Fluorouracil